Clinical Trials Browser

Phase 1 × NIH × palbociclib × Clear all

NCT02159755 2026-03-19

Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma

Phase 1 Active not recruiting

Lymphoma, Mantle-Cell